用于治疗过度活跃膀的β-3激动剂和抗胆固醇药物的处方模式
Grace Khaner1, Gregory Vurture2, Niharika Malviya3
1Albert Einstein College of Medicine, Bronx, NY.
Urology
|October 10, 2025
概括
过度活跃的膀药物的处方模式显示,较新的β-3激动剂受到城市专家的青,而较旧的抗胆固醇药在各种实践和环境中得到了更广泛的使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 过度活跃的膀 (OAB) 影响着数百万人,需要多种不同的治疗选择.
- 抗胆固醇和β3激动剂药物是OAB的关键药物治疗方法.
- 了解处方趋势对于优化OAB管理至关重要.
研究的目的:
- 分析针对OAB的抗胆固醇和β3激动剂药物的处方模式.
- 识别与处方特定OAB药物相关的提供者特征.
- 评估采用较新的OAB药物与已建立的药物之间的差异.
主要方法:
- 对医疗保险D部分索赔数据 (2013-2023) 的回顾性分析.
- 包括来自医疗保险和医疗补助服务中心数据的提供者特征.
- 单变量分析使用一个样本的比例测试来比较提供者子集.
主要成果:
- 从2013年到2023年,超过257,000名医疗服务提供者处方OAB药物.
- 泌尿科医生和妇产科医生显示,β-3激动剂的利用率更高,特别是在批准后的早期.
- 在城市处方者中,β-3激动剂的使用更为普遍,Mirabegron和Vibegron在城市中占据了显著的优势.
结论:
- 较新的OAB药物的服用是有限的,特别是在非城市地区和非专业人士中.
- 与较旧的抗胆固醇药物相比,对于较新的β-3激动剂存在不同的处方模式.
- 较旧药物的更广泛采用可能来自于跨专业和实践环境的更广泛应用.
相关概念视频
01:26Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
01:24Cholinergic Antagonists: Pharmacokinetics
897
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
897
01:28Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
01:18Adrenergic Agonists: Therapeutic Classification
1.4K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.4K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.6K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.6K